146 related articles for article (PubMed ID: 34481813)
1. Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma.
Hosseini F; Alemi F; Malakoti F; Mahmoodpoor A; Younesi S; Yousefi B; Asemi Z
Biochem Pharmacol; 2021 Nov; 193():114758. PubMed ID: 34481813
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
[TBL] [Abstract][Full Text] [Related]
4. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
[TBL] [Abstract][Full Text] [Related]
5. miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.
Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Deng Y
Cell Cycle; 2019 Dec; 18(23):3325-3336. PubMed ID: 31601147
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
7. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Wang W; Xu J; Li L; Dong Q; Shi Q; Zuo G; Zhou L; Weng Y; Tang M; He T; Luo J
Oncol Rep; 2013 Oct; 30(4):1723-30. PubMed ID: 23917613
[TBL] [Abstract][Full Text] [Related]
9. Wnt pathway in osteosarcoma, from oncogenic to therapeutic.
Cai Y; Cai T; Chen Y
J Cell Biochem; 2014 Apr; 115(4):625-31. PubMed ID: 24190862
[TBL] [Abstract][Full Text] [Related]
10. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‑catenin signaling in osteosarcoma by targeting the miR‑3666/KLF7 axis.
Huang A; Jin S; Han W; Wang Y; Ma S; Wang Z; Lin K; Zou Q; Zhou J; Li Z; Chen L
Int J Mol Med; 2021 Jan; 47(1):387-396. PubMed ID: 33416089
[TBL] [Abstract][Full Text] [Related]
12. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.
Zhang ZC; Liu JX; Shao ZW; Pu FF; Wang BC; Wu Q; Zhang YK; Zeng XL; Guo XD; Yang SH; He TC
Medicine (Baltimore); 2017 Jul; 96(27):e7245. PubMed ID: 28682874
[TBL] [Abstract][Full Text] [Related]
14. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-152 inhibits cell proliferation of osteosarcoma by directly targeting Wnt/β-catenin signaling pathway in a DKK1-dependent manner.
Zhao X; Sun S; Xu J; Luo Y; Xin Y; Wang Y
Oncol Rep; 2018 Aug; 40(2):767-774. PubMed ID: 29845282
[TBL] [Abstract][Full Text] [Related]
16. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
17. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
[TBL] [Abstract][Full Text] [Related]
18. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
Wu Z; Shi W; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
[TBL] [Abstract][Full Text] [Related]
20. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
